Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Nerve gliding exercises may ease diabetic nerve pain and improve balance

NCT ID NCT07210203

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding nerve gliding exercises (neural mobilization) to standard balance training can reduce pain, improve balance, and boost quality of life in people with diabetic neuropathy. Thirty-two adults aged 50-75 with type 2 diabetes and nerve pain will be split into two groups: one gets nerve exercises plus balance training, the other gets balance training alone. Both groups also receive standard physical therapy. The trial lasts six weeks and measures pain, balance, and quality of life before and after treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
neural mobilization (nerve gliding exercises) plus balance training
What this could lead to
If it works, this could offer a simple, drug-free way to reduce pain and improve balance and daily life for people with diabetic neuropathy.
What could go wrong
This is a small, early-stage trial with only 32 participants, so results may not apply widely. The treatment is an add-on, not a cure, and benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 32 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Jan 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Both genders. * Diagnosed cases of Diabetic Peripheral Neuropathy * Age 50-75 years. * Patients having history of type 2 Diabetes for at least 5 years. * Presence of neuropathic symptoms (pain, numbness, tingling, balance issues). * Patient having mild to moderate pain according to NPRS Exclusion Criteria: * Patients with Neurological Disorders like Stroke, multiple sclerosis, Parkinson's disease. * Chronic Pain Conditions or Conditions unrelated to DPN (e.g., fibromyalgia, osteoarthritis). * Foot Ulcers/Infection: Active ulcers or infections on lower limbs. * Uncontrolled Diabetes * Severe Balance Impairment Individuals unable to perform basic balance tests (e.g., unable to stand unaided for a few seconds).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic neuropathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Foundation University College of Physical Therapy

    RECRUITING

    Islamabad, 46000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.